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Abstract
Objective: We investigated positive and negative subjective well-being in relation to lower-extremity peripheral artery
disease (PAD) in a sample of older adults.
Method: 4760 participants in the English Longitudinal Study of Ageing (ELSA) provided baseline data on symptomatic
PAD, sociodemographic characteristics, lifestyle risk factors, and co-morbid conditions. Baseline and two-year follow-up
data were available for life satisfaction, quality of life, and depressive symptoms.
Results: Participants with PAD symptoms had lower baseline levels of life satisfaction (b¼0.03, p< .05) and quality of
life (b¼0.04, p< .01), and more depressive symptoms (b¼ 0.03, p< .05). These associations remained statistically
significant in multivariate analyses. Baseline PAD did not, however, influence well-being levels at two-year follow-up.
Discussion: Greater awareness of the potential for chronic vascular morbidity to disrupt the lives of older adults is
needed to inform effective multidisciplinary support and interventions that help maintain the quality of life of those
affected.
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Introduction
Subjective well-being is a multifaceted concept reflect-
ing both positive and negative dimensions.1,2 The pos-
itive aspects of well-being reflect how individuals judge
their quality of life based on their own standards of
what constitutes a good life (this reflects their satisfac-
tion with life or evaluative well-being) and their per-
ceived control over their lives and ability to enjoy it
(also known as ‘flourishing’ or eudemonic well-being).
On the other hand, the negative aspect of persons’ well-
being consists of moods and emotions, including feel-
ing of sadness and anxiety (also known as negative
affective well-being). As a marker of successful
ageing, much effort has been made to document differ-
ent well-being dimensions across the life course and to
study their diverse determinants in later life.3–5
Importantly, well-being and health are positively cor-
related6; this relationship may become increasingly
important at older ages, not least because of the
strong association between advancing age and preva-
lence of chronic illness, including atherosclerotic car-
diovascular disease (CVD), which constitutes a major
cause of mortality and ill health globally.7–9
With advancements in life expectancy and cardio-
vascular therapeutic improvements, maintaining life
quality in older survivors remains an important goal
given the potential of CVD to disrupt the lives of
1Geller Institute of Ageing and Memory, School of Biomedical Sciences,
University of West London, London, UK
2Usher Institute for Population Health Sciences, University of Edinburgh,
Edinburgh, UK
Corresponding author:
Snorri Bjorn Rafnsson, Geller Institute of Ageing and Memory, School of
Biomedical Sciences, University of West London, St. Mary’s Road, Ealing,
London W5 5RF, UK.
Email: Snorri.Rafnsson@uwl.ac.uk
JRSM Cardiovascular Disease
Volume 0: 1–10
! The Author(s) 2020
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/2048004020961717
journals.sagepub.com/home/cvd
individuals by limiting their psychosocial capacity,
functional status and productivity.7,10,11 There is grow-
ing evidence documenting the diverse impact of differ-
ent CVDs on the lives of older adults,12 including those
suffering from peripheral artery disease (PAD), defined
as atherosclerosis of the distal aorta and/or lower-limb
arteries causing arterial narrowing and disruption of
blood flow to the legs.13 The prevalence of PAD rises
steeply with age and affects a substantial proportion of
older adults.14 It commonly presents as intermittent
claudication, that is, pain usually in the calf occurring
on exertion and resolving after rest; more severe forms
of clinical disease include rest pain, gangrene or ulcer-
ation, occasionally leading to amputation.15,16
As a marker of generalised atherosclerosis, PAD
risk factors mirror other forms of CVD; for example,
smoking and type-2 diabetes are important factors
associated with the development of clinical disease.
Co-morbidity (e.g. coronary heart disease) is also
highly prevalent and CVD mortality risk is elevat-
ed.13,17 The impact of PAD on individuals’ physical,
psychological and social functional capacity has also
attracted research interest. In the majority of investiga-
tions to-date, the main study outcome is health-related
quality of life (HRQoL), which reflects persons’
appraisal of their current level of functioning, often
their ability to carry out predefined tasks.18,19 Several
small-scale studies of selected patient samples have
reported reduced HRQoL levels in persons with symp-
tomatic PAD20–23 and amputees.22,23 On the other
hand, comprehensive evidence from community-
derived samples of older survivors with PAD is lacking
although two previous Scottish cross-sectional investi-
gations24,25 observed lower HRQoL in individuals with
claudication (compared to those without symptoms)
which was mainly attributed to poor physical capacity
(mental functioning remained intact).
There is consensus that well-being denotes a broader
concept than HRQoL given that it includes different
evaluations of non-health related features of life,18,26
such as being able to enjoy oneself or plan for the
future. Importantly, impaired health does not necessar-
ily equate to low well-being; in fact, there may be sit-
uations where persons may not be expected to return to
normal activities yet manage to overcome disease-
specific limitations (e.g. reduced walking distance)
and adjust their lives accordingly.19 In the context of
living well with PAD, however, there is very limited
evidence on the impact of lower-limb morbidity on
the broader aspects of well-being, whether positive or
negative, which extend beyond persons’ ability to com-
plete specific activities. Moreover, well-being levels
are subject to substantial deterioration over time,
especially in older adults in whom such decline is
linked to progressive physical and mental
impairment.1,27 Given the current absence of relevant
longitudinal evidence, however, it is not clear how any
changes in well-being levels compare in older survivors
with and without PAD, or to what extent lower-
limb morbidity affects different well-being facets over
time.
Our aim was to determine the above relationships in
a sample of participants in the English Longitudinal
Study of Ageing (ELSA), a large nationally represen-
tative panel study of people aged 50 years and older.
Our objectives were three-fold: 1) to determine the
direction and magnitude of any associations between
symptomatic PAD and three indicators of positive (life
satisfaction, quality of life) and negative (depressive
symptoms) well-being; 2) to determine any differential
associations between PAD and specific well-being indi-
cators; and 3) to determine whether any observed asso-
ciations existed independently of relevant potential
confounding factors. Based on the previous evidence
of the impact of morbidity on well-being in older
adults,27 we hypothesised that symptomatic PAD
would be associated with lower positive, and higher
negative, well-being levels. We also hypothesised
that baseline PAD would be associated with greater
deterioration in well-being over a two-year follow-up
period.
Methods
Data and sample
The ELSA is a study of adults aged 50 years and over,
who were living in private households in England at the
time of the first wave of fieldwork in 2002/2003.
Sampling and data collection procedures in ELSA
have previously been described in detail.28 Briefly,
respondents in wave one (the baseline sample in
ELSA), were approached two years later for a second
wave (in 2004–2005) which provides the baseline data
for the present analysis, as this was the first time infor-
mation on symptomatic PAD was collected.
Specifically, information on PAD symptoms, well-
being measures and potential confounders were gath-
ered from a total of 8,780 core participants using a
computer assisted personal interview (CAPI) during a
home visit and a self-completion questionnaire to be
returned by post. The sample for the present investiga-
tion was restricted to 4760 core ELSA participants with
complete outcome data at waves two (2004–2005) and
three (2006–2007). Written informed consent was
obtained from all participants, and ethical approval
was granted by a Multicentre Research Ethics
Committee (MREC).
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Peripheral artery disease
The presence of lower-extremity PAD was determined
based on the Edinburgh Claudication Questionnaire
(ECQ) which relies on self-report of lower-limb symp-
toms.29 To qualify as having definite or typical claudi-
cation, a respondent needs to: 1) experience pain or
discomfort on walking; 2) not get it when standing
still or sitting; 3) the pain disappears in 10minutes or
less after rest; 4) experience the pain in the calf. Based
on these criteria, the following classification of claudi-
cation case status was derived: 1) No PAD symptoms;
2) Typical Grade 1 claudication (applies if person expe-
riences the pain when walking uphill or when in a
hurry); and 3) Typical Grade 2 claudication (applies
if individual experiences the pain when walking at an
ordinary pace on level ground). For the purpose of the
present analysis, participants reporting Grade 1 and
Grade 2 claudication were combined and compared
with those without such symptoms. Moreover, the
presence of atypical claudication (i.e. pain in the
thigh or buttocks in the absence of calf pain) or other
atypical leg pain was not considered in this
investigation.
Well-Being measures
Life satisfaction. The Satisfaction with Life Scale
(SWLS), which consists of five items, was used to
assess how satisfied participants were with his or her
life.30 Responses are based on a seven-point scale (rang-
ing from strongly disagree to strongly agree). A typical
SWLS item would be ‘In most ways my life is close to
my ideal’. For the present analysis, responses were
reversed and re-scaled, then summed for a total scale
score ranging from 0 to 30; higher scores indicate great-
er overall satisfaction with life (Cronbach’s alpha at
waves two and three was 0.896 and 0.901, respectively).
Quality of life. Quality of life was determined using
CASP-19, which is a summative scale of 19 items,
comprising four main domains: control, autonomy,
self-realization and pleasure.31 The scale includes
both positively and negatively worded statements, one
example being ‘I enjoy the things I do’. Each statement
is scored on a four-point scale: ‘never’, ‘not often’,
‘sometimes’ and ‘often’. For the present purpose, indi-
vidual items were added to create a total score, ranging
from 0 to 57; higher scores represented greater life
quality (Cronbach’s alpha ranged from 0.872 to 0.884
across waves two and three).
Depressive symptoms. Symptoms of depression were
assessed using the eight-item Center for
Epidemiologic Studies Depression Scale (CES-D),
which is a brief self-report scale designed to measure
depressive symptomatology in the general popula-
tion.32 Responses to all eight dichotomous questions
(e.g. a typical question being ‘how much of the time
during the past week did you feel sad?’) were combined
to create a total scale score, ranging from 0 to 8, with
higher scores indicating a greater degree of depression.
The eight-item version has good internal consistency
(Cronbach’s alpha ranged from 0.789 at wave two to
0.786 at wave three) and other psychometric properties
comparable to the full 20-item CES-D scale.
Confounding variables
Based on the approach used in previous comparable
studies,24,25 an a priori model was specified which
included the following potential confounders: Age (cat-
egorised into four age groups i.e. 50–59, 60–69, 70–79
and 80þ); Gender (male versus female); Relationship
status (married or cohabiting versus neither i.e. single,
divorced or widowed); Total (non-pension) wealth,
used here as an indicator of socioeconomic status;
Highest education level completed (no qualification,
intermediate, degree or higher); Smoking status
(never, former or current smoker); Sedentary lifestyle
(sedentary versus low to high physical activity); and
self-reported doctor’s diagnosis of diabetes (yes/no)
and angina pectoris (yes/no).
Statistical analysis
Descriptive analyses were performed on baseline data
stratified for participants with or without PAD. Non-
pension wealth was divided into quintiles because its
distribution was positively skewed. Age was used as a
four-level categorical variable in bivariate analyses but
as a continuous variable in multivariable analyses.
Pearson v2 (Chi-square) was used to test relationships
between binary categorical variables; for assessment of
trends for ordinal categorical variables, the v2 trend
(Linear-by-Linear Association) test was used. An
independent-samples t-test was conducted to compare
well-being levels at baseline and follow-up in those with
and without PAD.
Multiple hierarchical linear regression analysis was
used for modelling the association between lower-limb
symptoms and individual well-being measures. First,
we determined the cross-sectional relationship between
PAD and well-being at baseline, adjusting only for age
and gender, followed by progressively introducing
other potential confounding variables into the model.
In a second step, we determined the influences of PAD
on follow-up well-being levels using lagged hierarchical
regression models that first adjusted for age, gender
and the respective baseline well-being measure, fol-
lowed by successively adding other confounding
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variables. Using the baseline measure of the dependent
variable as a covariate is considered superior to using
raw change scores as it obviates the potential spurious
correlation between baseline and change scores.33
The following major assumptions underlying multi-
ple linear regression analysis were assessed using rele-
vant graphs and statistics: multicollinearity was
checked for using Tolerance/variance inflation factor
(VIF) values; the independence of residuals was tested
for using the Durbin-Watson statistic; homoscedastic-
ity and distribution of residuals were determined
through visual inspection of relevant scatter plots;
Cook’s Distance values were computed to assess the
presence of outliers or significant data points. Overall
model goodness-of-fit was determined based on the
total variance explained or R2. All statistical tests
were two-tailed and p values< .05 were considered to
be statistically significant. All data analyses were per-
formed using IBM SPSS Statistics version 24.
Results
Baseline sample characteristics
We excluded 4020 ELSA participants without complete
follow-up well-being data, leaving 4760 individuals for
the present analysis. Compared to those not included in
the analysis, the analytical sample proved to be: com-
paratively younger at baseline (p< .001); included
more men (¼ .038); was better educated (p< .001);
was better off socioeconomically (p< .001); was more
likely to have never smoked (p< .001); and had less
diabetes (p< .001) and angina (p< .001). In contrast,
the baseline frequency of PAD did not differ statisti-
cally between the two samples (p¼ .17).
Table 1 compares the baseline characteristics of ana-
lytical sample participants with and without PAD.
Participants with PAD proved to be comparatively
older (p< .001), more likely to be single (p¼ .004),
and were both less educated (p< .001) and well-to-do
Table 1. Baseline characteristics of analytical sample participantsa with and without symptomatic peripheral artery disease (PAD).b
Variables
No symptoms
(n¼ 4633)
PAD symptoms
(n¼ 127) p valuec
Age, % (n)
50–59 35.7 (1654) 20.5 (26)
60–69 36.5 (1691) 31.5 (40)
70–79 21.7 (1007) 32.3 (41)
80þ 6.1 (281) 15.7 (20) <.001
Gender, % (n)
Female 53.9 (2498) 51.2 (65) .54
Relationship Status, % (n)
Married/cohabiting 74.3 (3443) 63.0 (80) .004
Education, % (n)
No qualification 28.6 (1324) 49.6 (63)
Intermediate 55.3 (2563) 43.3 (55)
Degree or higher 16.1 (745) 7.1 (9) <.001
Non-pension wealth, % (n)
Lowest quintile 17.2 (788) 32.3 (41)
2nd 19.4 (886) 22.0 (28)
3rd 19.9 (910) 15.0 (19)
4th 21.2 (971) 17.3 (22)
Highest quintile 22.3 (1019) 13.4 (17) <.001
Smoking status, % (n)
Never smoker 38.9 (1803) 17.3 (22)
Former smoker 48.2 (2235) 51.2 (65)
Current smoker 12.9 (596) 31.5 (40) <.001
Sedentary lifestyle, % (n)
Yes 2.3 (108) 3.9 (5) .24
Diabetes, % (n)
Yes 6.3 (293) 15.7 (20) <.001
Angina Pectoris, % (n)
Yes 8.2 (380) 26.0 (33) <.001
a4760 core ELSA participants with complete outcome data at Waves two and three.
bPersons with typical grades 1 and 2 combined.
cProbability values were derived using either Pearson Chi Square test (test of difference between two proportions) or Linear by Linear Association test
(test of trend for ordinal categories).
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socioeconomically (p < .001). The presence of lower-
limb symptoms was also related to significantly higher
levels of current and former smoking (p< .001), and to
a higher prevalence of both comorbid diabetes
(p< .001) and angina (p< .001).
Peripheral artery disease and well-being levels
As shown in Table 2, participants with PAD had com-
paratively lower life satisfaction levels at baseline
(p¼ .003); although the mean levels declined for both
groups over time, these differences persisted at the
two-year follow-up (p¼ .009). Similarly, the mean qual-
ity of life levels at baseline (p< .001) and follow-up
(p< .001) were also found to differ statistically between
those with and without PAD despite deteriorating over
time in both groups. Lastly, participants with PAD
showed statistically higher levels of depressive symptoms
at both baseline and follow-up (p< .001 and p¼ .015,
respectively) despite declining in both groups over time.
Multivariate associations between peripheral artery
disease and well-being at baseline
The results from the multiple linear regression analysis
of the cross-sectional relationship between PAD and
individual well-being measures are shown in Table 3.
After adjusting for age and gender (model 1), PAD was
associated with both lower levels of life satisfaction
(b¼0.05, p< .001) and quality of life (b¼0.07,
p< .001). Moreover, PAD was also related to compar-
atively higher levels of depressive symptoms (b¼ 0.06,
p< .001). After progressively controlling for socioeco-
nomic factors (model 2), lifestyle factors (model 3) and
comorbid conditions (model 4), all associations
remained statistically significant, albeit reduced in mag-
nitude. Of the three well-being indicators, the greatest
relative influence of PAD was observed for quality of
life.
Multivariate associations between baseline
peripheral artery disease and follow-up well-being
Table 4 shows the results from the lagged linear regres-
sion analysis which modelled the relationship between
baseline PAD and follow-up well-being levels. After
adjusting for age, gender and the relevant baseline
well-being measure (model 1), we observed a negative
yet statistically non-significant influence of PAD on
both life satisfaction (b¼0.01, p> .05) and quality
of life (b¼0.01, p> .05). The association with
depressive symptoms was positive and also
Table 2. Unadjusted comparisons of well-being levels (means, standard deviation) at baseline and two-year follow-up in participants
with and without peripheral artery disease (PAD).a
PAD status
Life satisfaction
Baseline Follow-up
Mean SD Mean SD
No symptoms 21.6 5.9 20.3 6.2
PAD symptoms 19.9 6.6 18.8 6.6
MD (95% CI)b, p value 1.70 (0.56 to 2.64), .003 1.45 (0.37 to 2.58), .009
Quality of life
Baseline Follow-up
Mean SD Mean SD
No symptoms 43.6 8.2 41.9 8.4
PAD symptoms 39.7 8.6 37.8 8.1
MD (95% CI), p value 3.90 (2.43 to 5.33), < .001 4.05 (2.58 to 5.52), < .001
Depressive symptoms
Baseline Follow-up
Mean SD Mean SD
No symptoms 1.32 1.78 1.24 1.77
PAD symptoms 1.94 2.13 1.63 1.97
MD (95% CI), p value 0.62 (0.31 to 0.94), < .001 0.39 (0.07 to 0.70), .015
aPersons with typical grades 1 and 2 combined (typical grade 1 applies if a person experiences the pain when walking uphill or when in a hurry while
typical grade 2 applies if a person experiences the pain when walking at an ordinary pace on level ground).
bMD (mean difference) and 95% confidence intervals.
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non-significant (b¼ 0.00, p> .05). Further adjustment
for confounding factors (models 2–4) resulted in pro-
gressively weaker, non-significant associations.
Discussion
To the best of our knowledge, the present investigation
is the first to report on the influence of symptomatic,
lower-extremity PAD on both positive and negative
aspects of well-being in a large population sample of
relatively healthy and socioeconomically affluent older
adults. Specifically, our results extend the current evi-
dence by demonstrating an association of PAD with
reduced life satisfaction and quality of life, as well as
greater depressive symptoms. After adjusting for
important potential confounders, including socioeco-
nomic characteristics, lifestyle factors, and comorbid
conditions, the independent effects of PAD symptoms
remained, albeit reduced in magnitude. On the other
hand, we failed to observe any independent influences
of baseline PAD on follow-up well-being levels.
Direct comparison of the present results with those
from earlier studies is hampered by differences in study
design and methodology, including the type of study
sample and methods employed for both exposure and
outcome assessment. Only a few population-based
investigations have examined quality of life in relation
to symptomatic PAD in older adults. Two previous
cross-sectional investigations by Inglis et al.25 and
Dumville et al.24 observed comparatively lower overall
HRQoL levels in persons with claudication in multivar-
iate analyses. In both instances, HRQoL was deter-
mined using generic health status instruments (SF-12
and SF-36, respectively) which reflect domain-specific
functional and role limitations, including pain, discom-
fort, and reduced mobility. The use of such HRQoL
instruments for measuring quality of life has been
called into question as they only measure self-
perceived health status.18 In contrast, broader positive
well-being reflects individuals’ conscious judgment of
the quality of, and satisfaction with, their life. In
other words, commonly-used HRQoL questionnaires
tend to assess what patients should be able to do
rather than what they themselves consider to be impor-
tant in life.
These broader well-being dimensions are rarely
included in HRQoL questionnaires; yet poor positive
well-being has been associated with reduced longevity
and a greater chronic disease risk.34 As a marker for
successful ageing, positive well-being of older adults
has increasingly become an important objective for
both financial and health policy.6 In this context, our
study adds relevant evidence on the negative impact of
chronic PAD on older adults’ satisfaction with, and
quality of, life, including their sense of autonomy and
Table 3. Multiple linear regression models of the relationships between peripheral artery disease (PAD) and subjective well-being at
baseline.
Life satisfaction Quality of life Depressive symptoms
Model Covariates PAD status B b B b B b
1 Age, gender No symptoms Ref. — Ref. — Ref. —
PAD symptoms –1.86 (0.53) –0.05*** –3.73 (0.74) –0.07*** 0.63 (0.16) 0.06***
F for DR2 13.373*** 12.343*** 40.451***
2 Age, genderþ socioe-
conomic factorsa
No symptoms Ref. — Ref. — Ref. —
PAD symptoms –1.32 (0.50) –0.04** –2.75 (0.71) –0.05*** 0.50 (0.16) 0.04**
F for DR2 186.209*** 149.178*** 68.967***
3 Age, genderþ socioe-
conomic fac-
torsþ lifestyle
factorsb
No symptoms Ref. — Ref. — Ref. —
PAD symptoms –1.21 (0.50) –0.03* –2.55 (0.71) –0.05*** 0.46 (0.16) 0.04**
F for DR2 7.080** 39.815*** 21.837***
4 Age, genderþ socioe-
conomic fac-
torsþ lifestyle
factorsþ
comorbidityc
No symptoms Ref. — Ref. — Ref. —
PAD symptoms –1.06 (0.50) –0.03* –2.07 (0.71) –0.04** 0.39 (0.16) 0.03*
F for DR2 5.043** 26.018*** 12.684***
Overall model fit (R2) 0.12*** 0.12*** 0.08***
Note: B¼ unstandardized coefficients (standard errors are reported in parentheses). b¼ standardised coefficients.
aSocioeconomic factors: Education, non-pension wealth, relationship status.
bLifestyle factors: Smoking, sedentary lifestyle.
cComorbidity: Diabetes, angina. *p< .05; **p< .01; ***p< .001. Ref: Reference.
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control. Leading a high quality life is based on the
premise that individuals feel in control of their lives
and can choose what activities they engage in and
when.31 Individuals with PAD, however, may feel
their life is restricted and beyond their control.35 For
some, it means fluttering between wellness when
remaining indoors, or sitting still, and illness when
ambulating; the onset of lower-limb pain or discomfort
may force them to learn how to move around in new
ways, and any attempts towards maintaining normal
life is likely to require thorough planning and continual
adjusting.35,36
Similarly, we observed relatively more depressive
symptoms in participants with PAD which corrobo-
rates some previous cross-sectional reports of a
higher prevalence of depressive symptoms among dis-
eased individuals.37 In contrast, multivariate analyses
by Inglis et al.25 and Dumville et al.24 did not show any
significant differences in HRQoL mental health sub-
component scores between participants with and with-
out PAD. Although this discrepancy may to an
unknown extent be attributed to between-study
differences in the measurement of depressive symp-
toms, more recent findings based on a similar geriatric
depression scale to the one used in the present study
show comparatively higher prevalence and incidence of
depressive symptoms in persons with PAD.38 Negative
affective experiences in these individuals may partly
stem from fear of experiencing leg pain; furthermore,
their ability to be spontaneous may be reduced which
may force them to give up long-favoured activities,
including travelling, hiking etc.35 Fear of pain may
also result in stress, frustration and other negative emo-
tional reactions. For many, living with symptomatic
PAD means leading a strenuous life with a largely
invisible condition.39 Such existence may negatively
impact on their self-identity and pride. Lastly, feelings
of sadness about their changed life, and concerns about
the future that are associated with living with systemic
vascular disease, are commonly expressed by individu-
als with PAD.35,36
An examination of our multivariate models shows
that, for the three well-being measures, the associations
with PAD were attenuated following the adjustment
Table 4. Multiple linear regression models of the relationships between baseline peripheral artery disease (PAD) and follow-up
subjective well-being levels.
Life satisfaction Quality of life Depressive symptoms
Model Covariates PAD status B b B b B b
1 Age, gender, baseline
well-being
No symptoms Ref. — Ref. — Ref. —
PAD symptoms –0.33 (0.40) –0.01 –0.79 (0.50) –0.01 0.03 (0.14) 0.00
F for DR2 1144.691*** 1584.778*** 445.468***
2 Age, gender, baseline
well-beingþ
socioeconomic
factorsa
No symptoms Ref. — Ref. — Ref. —
PAD symptoms –0.26 (0.40) –0.01 –0.64 (0.50) –0.01 –0.06 (0.14) –0.00
F for DR2 12.645*** 18.952*** 47.008***
3 Age, gender, baseline
well-beingþ
socioeconomic
factorsþ
lifestyle factorsb
No symptoms Ref. — Ref. — Ref. —
PAD symptoms –0.17 (0.40) –0.01 –0.64 (0.49) –0.01 –0.09 (0.14) –0.01
F for DR2 10.257*** 4.665** 8.799***
4 Age, gender, baseline
well-beingþ
socioeconomic fac-
torsþ lifestyle
factorsþ
comorbidityc
No symptoms Ref. — Ref. — Ref. —
PAD symptoms –0.11 (0.40) –0.00 –0.53 (0.50) –0.01 –0.12 (0.14) –0.01
F for DR2 1.771 3.336* 1.337
Overall model fit(R2) 0.50*** 0.58*** 0.30***
Note: B¼ unstandardized coefficients (standard errors are reported in parentheses); b¼ standardised coefficients. *p< .05; **p< .01; ***p< .001.
aSocioeconomic factors: Education, non-pension wealth, relationship status.
bLifestyle factors: Smoking, sedentary lifestyle.
cComorbidity: Diabetes, angina. Ref: Reference.
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for sociodemographic, lifestyle and comorbid factors.
This suggests that the well-being impact of PAD is
partly accounted for by these factors although addi-
tional mechanisms (not considered in our analysis)
may also be involved. Most importantly, PAD is asso-
ciated with a high burden of physical functional limi-
tations,40 including mobility loss, which may erode
well-being levels. For example, the onset of pain or
discomfort when ambulating, particularly when
attempting to walk faster or on slopes, may be the
most common barrier to physical activity in affected
individuals.41 In response, they may deliberately slow
their walking speed, or limit their walking activity, in
order to avoid exertional leg symptoms.40 As a marker
of impaired physical functioning, reduced walking dis-
tance has been found to be a significant predictor of
general health, physical and social function in those
with PAD.42
Furthermore, lower-limb vascular morbidity is asso-
ciated with diverse psychosocial experiences which may
adversely influence individuals’ perceived well-being.
For example, affected persons often lack appropriate
understanding of the underlying pathophysiology and
risk factors for PAD;41 PAD symptoms may also be
confused with other diagnoses, including chronic
venous or musculoskeletal conditions. Some individu-
als assume that their pain will dissipate with time,
whereas others consider their leg symptoms to be part
of normal ageing. Uncertainty about whether lifestyle
changes, such as walking, actually help or make the
condition worse, may be common.41 Persons with
PAD have also expressed lack of understanding and
empathy from others, including from health professio-
nals, resulting in feelings of being dismissed and left on
their own.39 Negative experiences such as these may
potentially induce feelings of anxiety and fear in
those affected by PAD37 which subsequently could
undermine their sense of independence or satisfaction
with life.
Study limitations and future directions
Some potential limitations of the present study should
be considered: First, the sample size available for the
present analysis was reduced due to missing data on
key variables. Although we are aware of the potential
benefits (and caveats) of known methods for imputing
missing data, we decided not the pursue this option in
light of the findings from some previous analyses of
well-being outcomes in ELSA that used multiple impu-
tation; despite increasing the available sample size,
these analyses produced similar results.43 Second,
although the ELSA study participants were drawn
from a nationally representative sample, our analytical
sample proved to be comparatively healthier and more
socioeconomically advantaged compared to those
excluded from the analysis. As such, the present find-
ings may not directly generalise beyond the study
sample. Moreover, although our baseline data were
collected in 2005, we consider them to be still clinically
relevant because 1) the specific PAD and well-being
measures we employed continue to be valid and
widely used in population studies;28 2) the prevalence
of PAD in the older adult UK population has declined
only slightly over the past two decades;44 3) a signifi-
cant proportion of older adults living with PAD fail to
receive guideline-recommended care and well-being
support,44 and; 4) the relevant evidence based remains
poor given that few investigations similar to the present
one have been undertaken since 2005. Third, it is pos-
sible that additional characteristics, not considered in
the present study (e.g. the duration of symptoms or
PAD treatment), might to an unknown extent have
confounded the association between PAD and well-
being. Fourth, we only examined well-being at two
waves, two-years apart. Our chosen well-being meas-
ures reflect broad experiences which may be influenced
by diverse conditions,6 health being only one, and yet
are unlikely to be subject to significant short-term fluc-
tuations. Possibly for these reasons, our initial predic-
tions were only partly met as we observed no
independent influence of baseline PAD on follow-up
well-being levels. Lastly, as with any cross-sectional
findings, we are limited in our ability to infer causality
between self-reporting of PAD symptoms and the three
well-being measures.
The present results suggest health professionals need
to be aware of the potential impact of chronic PAD on
both positive and negative aspects of well-being of
older adults. However, to better understand the influ-
ence of PAD on positive and negative well-being
domains, future studies should also examine well-
being in relation to other PAD syndromes, including
asymptomatic PAD which may be associated with
reduced functional performance.40 In addition, more
studies are needed that track symptomatic individuals
over time in order to determine any concomitant
changes in well-being levels; this is important given
that self-reported improvement or stabilisation of
PAD symptoms may actually be a response to the
underlying condition rather than improvement of func-
tional performance.40 Moreover, it is currently not
clear how the different aspects of the clinical care
(e.g. medical treatment, patient education etc.) provid-
ed to older adults with PAD influences their percep-
tions and experiences of living with chronic vascular
morbidity. Finally, in light of the growing evidence
linking positive and negative well-being with subse-
quent health outcomes,6,34 future research should con-
sider the potential prognostic role well-being measures
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might play (regarding treatment compliance, effective
lifestyle modification etc.) in the context of living with
lower-extremity vascular morbidity.
Conclusion
This investigation observed independent influences of
PAD symptoms on positive and negative well-being
levels among community-residing older participants
in the ELSA study. Specifically, older adults with
lower-limb symptoms were found to have lower levels
of both quality of life and satisfaction with life, and
more depressive symptoms. Further studies are
required to help elucidate the potential mechanisms
underlying this association, including how symptom
severity, comorbid conditions, or specific functional
limitations may act separately, or in combination, to
influence different aspects of the well-being of those
affected by PAD. With much emphasis nowadays on
maintaining quality of life of persons suffering from
vascular diseases, greater awareness of their potential
life-disrupting influences is needed to inform effective
multidisciplinary support and interventions for those
living and ageing with chronic vascular morbidity.
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